To determine whether TRPV4 is involved in age-related flow-induced blood vessel dilation impairment, we measured blood vessel diameter and nitric oxide (NO) levels and performed Ca 2+ imaging, immunoblotting, and immunostaining assays in rats. We found that the flow-induced and TRPV4 activator 4α-PDD-induced dilation of mesenteric arteries from aged rats were significantly decreased compared with those from young rats. The flow-or 4α-PDD-induced [Ca 2+ ] i rise was also markedly reduced in primary cultured mesenteric artery endothelial cells (MAECs) from aged rats. Immunoblotting and immunostaining results showed an age-related decrease of TRPV4 expression levels in MAECs. Additionally, the 4α-PDD-induced NO production was significantly reduced in aged MAECs. Compared with lentiviral GFP-treated aged rats, lentiviral vector delivery of TRPV4 increased TRPV4 expression level in aged MAECs and restored the flow-and 4α-PDD-induced vessel dilation in aged mesenteric arteries. We concluded that impaired TRPV4-mediated Ca 2+ signaling causes endothelial dysfunction and that TRPV4 is a potential target for clinical treatment of age-related vascular system diseases.
Shear stress generated from blood flow is an important physiological stimulus that triggers endothelial cell (EC)-mediated vascular dilation 1 . In this process, Ca 2+ signaling is also a well-documented component [2] [3] [4] . An increase in intracellular Ca 2+ concentration ([Ca 2+ ] i ) evokes the synthesis and release of endothelial vasodilators, including nitric oxide (NO), prostacyclin, and endothelium-derived hyperpolarizing factors (EDHFs), which subsequently act on smooth muscle, leading to vessel dilation. Several studies have demonstrated that the transient receptor potential vanilloid subtype 4 (TRPV4), a Ca 2+ permeable cation channel, facilitates the shear stress-mediated [Ca 2+ ] i increase 2, [5] [6] [7] [8] [9] . Shear stress activates TRPV4 channels in TRPV4-overexpressing HEK293 cells, human umbilical vein endothelial cells, or renal epithelial cells 5, 6, 10 . Moreover, TRPV4 forms a channel complex with TRPC1, TRPP2, or both to mediate Ca 2+ influx 9 . Elimination of TRPV4 in TRPV4 knockout (− /− ) mice significantly reduces endothelium-dependent vascular dilation initiated by blood flow and slightly lowers baseline mean arterial pressure 11 . Impaired endothelial function is considered a primary factor in aging, and it is a very early and important event leading to cardiovascular disease, such as vascular bed disorder, reported in both elderly animals and humans [12] [13] [14] [15] [16] . Without the presence of other cardiovascular risk factors, aging serves as an independent factor associated with endothelial dysfunction 17 . The current understanding of the mechanism underlying age-dependent endothelial dysfunction focuses on reduced NO bioavailability, enhanced oxidative stress, increased vasoconstrictor factor activity, and the development of a low-grade pro-inflammatory environment 18 . However, age-dependent changes of Ca 2+ the present study, we investigated the role of TRPV4 in flow-induced dilation impairment with aging and the potential value of TRPV4 in the clinical treatment of aging-related vascular system diseases.
Results
Changes in flow-induced vessel dilation and mesenteric artery ECs [Ca 2+ ] i rise with aging.
Flow-induced dilation was measured in rat mesenteric arteries derived from young (3 months old) and aged (22 months old) rats. Endothelium-intact mesenteric arteries were preconstricted to approximately 60% of their initial diameter using 1-3 μM phenylephrine (Phe). After stabilization, intraluminal flow was induced by a 10 mmHg pressure difference to elicit vascular dilation. We found that dilation was greatly reduced in mesenteric arteries derived from aged rats (Fig. 1A-C) . Because flow-induced dilatation correlates with endothelium function 4 , the decreased flow response in aged blood vessels reflects an impairment in EC function with advancing age. Ca 2+ signaling is crucial to the function of ECs for regulating vessel dilation. To determine whether the flow-induced [Ca 2+ ] i rise changes in aged mesenteric arteries ECs (MAECs), primary cultured MAECs were seeded on rectangular coverslip and mounted in a parallel flow chamber, where flow evoked a transient increase in [Ca 2+ ] i . We found that the flow-induced [Ca 2+ ] i rise in MAECs derived from aged rats was significantly lower than that in MAECs from young rats (Fig. 1D,E) . Therefore, this impaired flow-induced Ca 2+ signaling in ECs may decrease flow-induced vessel dilation.
Functional roles of TRPV4 in the flow-induced vessel dilation and MAEC [Ca 2+ ] i rise with aging.
Many studies have shown that TRPV4 contributes to flow-induced vessel dilation and flow-induced Ca 2+ rise 2, [5] [6] [7] [8] [9] . To confirm the contribution of TRPV4 in flow-induced vessel dilation and [Ca 2+ ] i rise in our hands, we used the TRPV4 antagonist RN1734. We found that RN1734 pretreatment strongly reduced the flow-induced dilation of mesenteric arteries ( Fig. 2A-C) as well as the flow-induced [Ca 2+ ] i rise in primary cultured MAECs derived from young rats (Fig. 2D,E) , consistent with previous reports 6, 7, 19, 20 . Next, to examine the involvement of TRPV4 in endothelium dysfunction, we investigated vessel dilation in response to application of the TRPV4 agonist 4α -PDD. Our data showed that applying 5 μM 4α -PDD elicited vessel dilation in Phe-precontracted mesenteric arteries derived from young rats (Fig. 3A,C) . However, the 4α -PDD-induced vessel dilation was markedly decreased in mesenteric arteries obtained from aged rats (Fig. 3B,C) . In addition, the 4α -PDD-induced [Ca 2+ ] i rise was nearly absent in aged primary cultured MAECs (Fig. 3D,E) . These results indicated that the TRPV4-mediated flow response is impaired in aged vessels.
TRPV4 expression level in MAECs decreases with aging.
Previous studies by others and our current study demonstrated a TRPV4-mediated endothelial Ca 2+ influx and vasodilation in response to shear stress 6, 7, 19, 20 . Additionally, our present data indicated that the TRPV4-mediated endothelial Ca 2+ influx and shear stress-induced vasodilation were largely reduced with aging. To further explore the underlying mechanism, we evaluated TRPV4 expression levels in young and aged cultured primary MAECs. Our results showed that TRPV4 expression levels in primary cultured MAECs derived from aged rats were decreased compared with those from young rats by Western blotting (Fig. 4A,B) . Our results from immunostaining assays further confirmed this finding (Fig. 4C ).
NO production in MAECs is reduced with aging. The [Ca 2+ ] i rise in ECs may induce the production of NO, which acts on smooth muscle to induce vessel dilation 21 . To explore whether processes downstream of the TRPV4-induced [Ca 2+ ] i rise were altered with aging, we measured the amount of NO production stimulated by 4α -PDD in primary cultured MAECs. The NO production was evaluated by examining the 4-amino-5-methylamino-2′ , 7′ -difluorofluorescein (DAF-DA) fluorescence signal. We found that the 4α -PDD-stimulated NO production in MAECs derived from aged rats was significantly reduced compared with that in young rats (Fig. 5) , indicating that impaired TRPV4 activity lowered NO production with aging. Increasing TRPV4 expression partially restores the deficits in flow-induced and TRPV4-mediated dilation in mesenteric arteries of aged rats. The results above show that the reduction in the flow-induced and TRPV4-mediated dilation of mesenteric arteries from aged rats was associated with a decrease in the TRPV4 expression level in these vessels. Therefore, we next elevated TRPV4 expression in ECs by generating a lentiviral construct carrying TRPV4 (lenti-TRPV4) and administering it intravenously to young and aged rats. Successful lentiviral transduction was confirmed by the observation of lenti-GFP fluorescence in the endothelial layer of the arteries. We found that the GFP fluorescence was enhanced significantly in the endothelial layer of lenti-GFP transfected mesenteric arteries ( Supplementary Fig. 2A ). To further confirm the transduction efficiency of lenti-TRPV4, we tested expression level of TRPV4 in young and aged MAECs. The results showed that TRPV4 expression level was statistically increased in aged MAECs, but only slightly increased in young MAECs when both young and aged MAECs were treated by lenti-GFP and lenti-TRPV4 ( Supplementary Fig. 2B,C) . More interestingly, we found that the impaired flow-evoked and 4α -PDD-induced dilation in mesenteric arteries from lenti-TRPV4-treated aged rats were significantly rescued compared with those from lenti-GFP-treated aged rats (Fig. 6A-D) . By contrast, lenti-TRPV4 transfection did not significantly affect flow-or 4α -PDD-induced dilation in mesenteric arteries derived from young rats (Fig. 6E,F) . In addition, lenti-TRPV4 transfection did not affect the vasoconstriction induced by application of a high K + solution in young and aged rats ( Supplementary Fig. 3 ). [Ca 2+ ] i rise and NO production, as the upstream signal in MAECs, importantly contribute to the vessel dilation. To uncover the underlying mechanism of lenti-TRPV4-increased flow-evoked dilation, we examined the effect of 4α -PDD on [Ca 2+ ] i rise and NO production in lenti-TRPV4 transduced young and aged MAECs. Consistent to the result of flow-induced dilation, [Ca 2+ ] i rise and NO production were significantly enhanced or recovered by lenti-TRPV4 transduction in aged MAECs, but only slightly increased in young MAECs without significant difference (Figs 7 and 8) . These results suggest that decreased TRPV4 expression may be a primary cause of endothelial function deficits in aged rats. The mesenteric arteries are proximal resistance vessels that substantially contribute to the majority of blood flow resistance in the circulation. Shear stress induced by blood flow acts on ECs to modulate smooth muscle tone and consequently blood vessel lumen diameter 22, 23 . ECs function in mechanotransduction, acting as an interface between flowing blood and the vessel wall. In ECs, sensing a flow-induced stimulus is the earliest stage in shear stress-induced mechanotransduction. The present study showed that flow-induced vessel dilation in mesenteric arteries derived from aged rats was significantly decreased compared with that in young rats. Therefore, vascular endothelial dysfunction occurs during aging and may be a critical risk factor for the development of cardiovascular diseases, such as atherosclerosis and hypertension.
The present study showed that the flow-stimulated [Ca and release of dilation factors, such as NO, prostacyclin, and EDHFs. NO contributes to blood pressure regulation, and the NO synthase inhibitor L-NAME increases blood pressure 24 . Therefore, if the agonist-or shear stress-induced [Ca 2+ ] i rise is blunted, the endothelium-dependent vessel dilation may be impaired. Previous studies have demonstrated that NO and the prostacyclin mediation of endothelium-dependent dilation were impaired in several types of vascular beds with aging 25 . However, the underlying molecular targets remained unknown. Our findings suggested that the reduced flow-stimulated [Ca 2+ ] i rise contributed to the decreased flow-induced vessel dilation in the mesenteric arteries of aged rats. More interestingly, we identified TRPV4 as a crucial molecular target responsible for endothelium dysfunction in aging.
Multiple TRP channels participate in flow-induced Ca 2+ influx, including TRPV4 2, 6, 19, 20 , TRPP2  26 ,  TRPV4-TRPC1   27   , TRPV4-TRPP2  8,28 and TRPV4-TRPC1-TRPP2   9 . However, in overexpressing systems, previous studies have shown that flow only evokes the [Ca 2+ ] i rise in TRPV4-expressing HEK293 cells, but not in HEK293 cells expressing TRPC1 or TRPP2 7, 8 . Our results are consistent with those from these previous studies, further indicating that TRPV4 is essential in shear stress-induced endothelial Ca 2+ influx and vasodilation. To reveal the pathological relevance of TRPV4 in the decreased flow response of aged mesenteric arteries, we examined the 4α -PDD-induced [Ca 2+ ] i rise and vessel dilation. Our data demonstrated that the 4α -PDD-induced response was significantly decreased in aged mesenteric arteries. The NO production induced by the TRPV4-mediated [Ca 2+ ] i rise was also decreased in aged MAECs. The immunoblotting and immunostaining data also showed that the TRPV4 expression level in aged MAECs was significantly reduced compared with that in young rats. These results suggested that an attenuated TRPV4-mediated [Ca 2+ ] i rise may result from the decreased TRPV4 expression level in aged MAECs. This hypothesis was confirmed using lenti-TRPV4 constructs to restore TRPV4 expression in aged rats. Impaired flow-or 4α -PDD-induced dilation was significantly recovered by restoring TRPV4 expression levels in aged rats. In addition to TRPV4, other TRP family members, such as TRPC3, have been suggested to play a role in flow-induced vasodilation in rat small mesenteric arteries 29 . Along with TRP channels, other molecular elements involved in flow stimulus sensing have been identified in ECs, including the cytoskeleton, tyrosine kinase receptors, caveolae, G proteins, and cell-matrix and cell-cell junction molecules 23, 30, 31 . Thus, multiple factors may contribute to the age-related impairment of ECs, and our data indicate that TRPV4-mediated Ca 2+ influx is one of the contributors to age-related impairment in MAECs.
In conclusion, our data suggested that the impairment of TRPV4-mediated Ca 2+ signaling in ECs contributed to the age-related decrease of flow-induced vessel dilation in mesenteric arteries. The present study sheds new light on the potential value of TRPV4 for clinical treatment of age-related vascular system diseases. But here we only provide a clue of the pathological relevance of TRPV4. Future study on age-related vascular system diseases, for example hypertension or atherosclerosis animal models, may benefit this important issue.
Methods
Cell preparation and culture. All animal experiments were conducted in accordance with the U.S. National Institutes of Health (NIH publication No. 8523) and were approved by the Animal Experimentation Ethics Committee of Anhui Medical University. Primary cultured MAECs were isolated from male Sprague Dawley rats (weight: 250-300 g; aged: 3 or 22 months) and maintained as previously described. Briefly, the rats were killed by CO 2 asphyxiation, and the heart was perfused with phosphate-buffered saline (PBS; 140 mM NaCl, 3 mM KCl, and 25 mM Tris; pH 7.4) to remove circulating blood. The small intestine was dissected. All vein branches of the mesenteric bed were rapidly excised, and the remaining arterial branches were digested with 0.02% collagenase type I (Sigma) in PBS for 45 min at 37 °C. The digested samples were centrifuged at 1600 × g for 5 min, and the pelleted cells resuspended in DMEM supplemented with 10% FBS, 100 μg/mL penicillin, and 100 U/mL streptomycin. One hour after plating the cells, the medium was changed to remove non-adherent cells. The remaining adherent MAECs were cultured at 37 °C with 5% CO 2 for 3-5 days. The identity of the primary cultured rat MAECs was verified by immunostaining using an antibody against von Willebrand factor. The results showed that 98% of cells were of endothelial origin ( Supplementary Fig. 1 ).
[Ca 2+ ] i measurement. [Ca 2+ ] i measurements were performed as previously described 4, 9 . Briefly, MAECs seeded on rectangular coverslips were loaded with 10 μM Fluo-8/AM and 0.02% pluronic F-127 for 30 min. The Vessel diameter measurement using a pressure myography system. Lenti-TRPV4 or lenti-GFP vector virus (1.0 × 10 7 copies) were intravenously injected in young and aged rats. Third-order mesenteric arteries were dissected from the rats 72 hrs later. Successful lentiviral transduction was confirmed by the observation of lenti-GFP fluorescence in the endothelial layer of the arteries. Vessel diameter measurements were performed as previously described 9 . Briefly, the mesenteric arteries were cut into segments 2-3 mm in length and then mounted in a pressure myograph chamber (Danish MyoTechnology, Denmark, model 110P) with two glass micropipettes. Both cannulation pipettes were connected to independent reservoirs set to the same level to ensure equal pressures and no flow in the vessel segments. The pressure myograph chamber was heated to 37 °C and filled with 5 mL of Krebs solution, which was continuously bubbled with a gas mixture of 95% O 2 and 5% CO 2 to maintain a pH of 7.4. After a 60 min equilibration period at 50 mmHg intraluminal pressure, the contractile function of the vessel was tested using a 60 mM K + solution. Following washout and a 30-min equilibration period, the artery was precontracted to approximately 60% of its initial vessel diameter by using 1-3 μM phenylephrine (Phe) to achieve a similar constriction among the various artery diameters. The flow was initiated by perfusing Krebs solution containing 1% BSA into the vessel lumen, or by adding 4α -PDD to the chamber to elicit vessel dilation. The external diameter of the artery was recorded continuously with a CCD camera using MyoView software (version 1.1 P, 2000, Photonics Engineering). Before each experiment, the endothelium viability was assessed by dilation with 1 μM acetylcholine after the preconstriction with 1 μM Phe. Intact vessels failing to achieve at least 80% of the maximal relaxation average were assumed to be damaged and were discarded.
Immunoblotting. Proteins were extracted from primary cultured MAECs lysates with detergent extraction buffer containing 1% Nonidet P-40, 150 mM NaCl, 20 mM Tris-HCl (pH 8.0) and protease inhibitor cocktail tablets (Sigma). Following protein transfer to a PVDF membrane, the membrane was incubated with a primary anti-TRPV4 antibody (1:200, Santa Cruz) at 4 °C overnight. The primary antibody was visualized with a horseradish peroxidase-conjugated secondary antibody (1:1000, GE Healthcare) that was processed with an enhanced chemiluminescence detection system (GE Healthcare). The optical density of each blot was normalized to that of β -tubulin (1:200, Santa Cruz), which was analyzed within the same lane, and presented as relative optical density.
Immunostaining. Immunostaining was performed as previously described 7, 9 with MAECs that were seeded onto circular coverslips and fixed with 4% formaldehyde for 10 min, followed by permeabilization with 0.1% Triton X-100 in PBS. The cells were blocked with 2% BSA at room temperature for 60 min and then incubated with primary anti-TRPV4 antibody (1:100) at 4 °C overnight. Following incubation, samples were washed three times with PBS and incubated with goat anti-rabbit IgG secondary antibody conjugated to Alexa Fluor 488 (1:200) for 60 min at room temperature. The samples were then washed three times with PBS, the coverslips were mounted using 90% glycerol in PBS, and the fluorescence was detected with a Leica TCS SP5 confocal laser system.
Measurement of NO production in primary cultured MAECs. MAECs seeded on circular coverslips were loaded with 2 μM 4-amino-5-methylamino-2′ , 7′ -difluorofluorescein (DAF-FM DA; Molecular Probes) at room temperature for 10 min. The fluorescence intensity excited at 495 nm and emitted at 515 nm was determined using a Leica TCS SP5 confocal laser system. The MAECs were stimulated with 5 μM 4α -PDD in NPSS. Changes in intracellular NO levels were displayed as a ratio of fluorescence (F 1 /F 0 ).
Statistical analysis.
Student's t-tests were used for comparisons of means from two groups, with P values less than 0.05 deemed significant.
